ATE63913T1 - Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung. - Google Patents

Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.

Info

Publication number
ATE63913T1
ATE63913T1 AT83108942T AT83108942T ATE63913T1 AT E63913 T1 ATE63913 T1 AT E63913T1 AT 83108942 T AT83108942 T AT 83108942T AT 83108942 T AT83108942 T AT 83108942T AT E63913 T1 ATE63913 T1 AT E63913T1
Authority
AT
Austria
Prior art keywords
pyrazolo
production
pyridine derivatives
lopyridines
ansiolytic
Prior art date
Application number
AT83108942T
Other languages
German (de)
English (en)
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE63913T1 publication Critical patent/ATE63913T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT83108942T 1982-09-22 1983-09-10 Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung. ATE63913T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23375/82A IT1154024B (it) 1982-09-22 1982-09-22 Derivati pridinici e procedimento per la loro produzione
EP83108942A EP0104522B1 (en) 1982-09-22 1983-09-10 New pyrazolo(3,4-b)pyridine derivatives and process for producing them

Publications (1)

Publication Number Publication Date
ATE63913T1 true ATE63913T1 (de) 1991-06-15

Family

ID=11206534

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83108942T ATE63913T1 (de) 1982-09-22 1983-09-10 Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.

Country Status (10)

Country Link
US (1) US4612318A (OSRAM)
EP (1) EP0104522B1 (OSRAM)
JP (1) JPS5989679A (OSRAM)
AT (1) ATE63913T1 (OSRAM)
CA (1) CA1248532A (OSRAM)
DE (1) DE3382299D1 (OSRAM)
ES (1) ES525786A0 (OSRAM)
GR (1) GR78987B (OSRAM)
IT (1) IT1154024B (OSRAM)
PT (1) PT77370B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
US4751226A (en) * 1985-09-12 1988-06-14 Fujisawa Pharmaceutical Co., Ltd. Pyrazoloisoquinoline derivatives, plant growth regulating compositions, and method of use therefor
JPH0615542B2 (ja) * 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5006520A (en) * 1987-10-13 1991-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrazole compounds and pharmaceutical use thereof
TW444018B (en) 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
AU687196B2 (en) * 1994-06-16 1998-02-19 Pfizer Inc. Pyrazolo and pyrrolopyridines
AU2001264313A1 (en) * 2000-06-20 2002-01-02 Japan Tobacco Inc. Pyrazolopyridine compounds and use thereof as drugs
US20040235794A1 (en) * 2001-09-04 2004-11-25 Shinji Nakade Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
EP1522314B1 (en) * 2002-06-26 2014-03-05 Ono Pharmaceutical Co., Ltd. Remedies for diseases caused by vascular contraction or dilation
CN1922150A (zh) 2004-02-27 2007-02-28 霍夫曼-拉罗奇有限公司 吲唑衍生物以及含有它们的药物组合物
EP1720878A1 (en) 2004-02-27 2006-11-15 F.Hoffmann-La Roche Ag Heteroaryl-fused pyrazolo derivatives
WO2005085249A1 (en) 2004-02-27 2005-09-15 F. Hoffmann-La Roche Ag Fused derivatives of pyrazole
CA2620105A1 (en) 2005-08-25 2007-03-01 F. Hoffman-La Roche Ag P38 map kinase inhibitors and methods for using the same
BRPI0707902A2 (pt) * 2006-02-15 2011-05-17 Abbott Lab pirazoloquinolonas são potentes inibidores parp
JP5739820B2 (ja) 2008-12-30 2015-06-24 アークル インコーポレイテッド 置換5,6−ジヒドロ−6−フェニルベンゾ[f]イソキノリン−2−アミン化合物
AU2009335016A1 (en) * 2008-12-30 2011-08-18 Arqule, Inc. Substituted pyrazolo [3, 4-b] pyridine compounds
WO2011159864A1 (en) * 2010-06-17 2011-12-22 Bracco Imaging S.P.A. Jte013 analogs and methods of making and using same
RU2495039C1 (ru) * 2012-07-31 2013-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-1,6-ДИФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-6-СТИРИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
WO2019038384A1 (en) * 2017-08-23 2019-02-28 Sprint Bioscience Ab AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403158A (en) * 1966-03-11 1968-09-24 Upjohn Co 1h-pyrazolo[3, 4-b]pyridines
US3681368A (en) * 1970-10-15 1972-08-01 Abbott Lab Pyrazolo naphthridines
BE787249A (fr) * 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
US3891630A (en) * 1974-03-04 1975-06-24 Abbott Lab Substituted pyrazolo{8 3,4-e{9 {8 1,4{9 thiazepines and isoxazolo{8 5,4-e{9 {8 1,4{9 thiazepines
US3903096A (en) * 1974-03-29 1975-09-02 Squibb & Sons Inc New derivatives of sulfonyl-, sulfinyl- and sulfenyl-1H-pyrazolo {8 3,4-b{9 -pyridines
EP0005745B1 (en) * 1978-05-26 1982-07-14 Gruppo Lepetit S.P.A. Pyrazolo (3,4-c) and thiazolo (5,4-c) isoquinolines, methods for preparing them, these compounds for use as antiinflammatory, cns-depressant and anti-anxiety agents and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0104522B1 (en) 1991-05-29
ES8503685A1 (es) 1985-03-01
JPS5989679A (ja) 1984-05-23
IT8223375A0 (it) 1982-09-22
CA1248532A (en) 1989-01-10
PT77370A (en) 1983-10-01
US4612318A (en) 1986-09-16
DE3382299D1 (de) 1991-07-04
ES525786A0 (es) 1985-03-01
PT77370B (en) 1986-04-21
EP0104522A2 (en) 1984-04-04
IT1154024B (it) 1987-01-21
GR78987B (OSRAM) 1984-10-02
EP0104522A3 (en) 1985-06-19

Similar Documents

Publication Publication Date Title
ATE63913T1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
EP0129128A3 (en) 2-pyrimidinyl-1-piperazine derivatives, process for their preparation and medicines containing them
ES2033400T3 (es) Procedimiento para producir preparados farmaceuticos estables.
ATE186728T1 (de) Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung
HUT37410A (en) Process for the production of benzothiazole- and benzothiophene-derivatives, as well as of therapeutic preparations containing them as agent
EP0045290A3 (en) Continuous process for the production of peroxycarboxylic acid compositions
ES8406467A1 (es) "procedimiento para preparar nuevos benzo b tiofenos".
ES545195A0 (es) Un procedimiento para preparar derivados de purina
ATE46518T1 (de) Sialosylcerebroside und verfahren zu ihrer herstellung.
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
IT8025223A0 (it) Procedimento per la produzione di derivati dell'acido penicillanico.
UA13319A (uk) СПОСІБ ОДЕРЖАHHЯ СКЛАДHИХ ЕФІРІВ 16,17-АЦЕТАЛЬЗАМІЩЕHОЇ АHДРОСТАH-17beta-КАРБОHОВОЇ КИСЛОТИ
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
PL248314A1 (en) Process for preparing derivatives of bicyclo/3,2,1/-octano-3-carboxylic acid
CS190550B2 (en) Method of producing 6,11-dihydro-11-oxodibenz/b,e/-oxepinalkanoic acid
DE3689764D1 (de) Zwischenprodukte und Verfahren zu ihrer Herstellung.
FR2331360A1 (fr) Procede de production d'un compose extincteur
ATE23340T1 (de) 3-alkylthio-2-0-carbamoylpropan-1,2-diol-1-0phosphocholine und verfahren zu ihrer herstellung.
ES8203087A1 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
ES472297A1 (es) Procedimiento para la preparacion de 1-metil-isoguanosina
HUT48599A (en) Process for producing 2-aminoisoquinoline derivatives and pharmaceutical compositions comprising the compounds
JPS51127060A (en) Process for preparing 4-homoisotwistane- exo-2-ol
ATA229386A (de) Verfahren zur herstellung von neuen pyrazolo (1,5-a) pyridinderivaten
HU174259B (hu) Sposob poluchenija 3,4-dikhloroanilida propionnojj kisloty
IE42464L (en) HEXAHYDRO-1H-INDENO [1,2-b] PYRIDINES

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee